These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31495634)

  • 41. Metabolic consequences of the incorporation of a Roux limb in an omega loop (mini) gastric bypass: evaluation by a glucose tolerance test at mid-term follow-up.
    Himpens JM; Vilallonga R; Cadière GB; Leman G
    Surg Endosc; 2016 Jul; 30(7):2935-45. PubMed ID: 26487198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nitrosative stress but not glycemic parameters correlate with improved neuropathy in nonseverely obese diabetic patients after Roux-Y gastric bypass.
    Müller-Stich BP; Billeter AT; Fleming T; Fischer L; Büchler MW; Nawroth PP
    Surg Obes Relat Dis; 2015; 11(4):847-54. PubMed ID: 25862183
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early effect of Roux-en-Y gastric bypass on insulin sensitivity and signaling.
    Severino A; Castagneto-Gissey L; Raffaelli M; Gastaldelli A; Capristo E; Iaconelli A; Guidone C; Callari C; Bellantone R; Mingrone G
    Surg Obes Relat Dis; 2016 Jan; 12(1):42-7. PubMed ID: 26483070
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity.
    Kelly AS; Ryder JR; Marlatt KL; Rudser KD; Jenkins T; Inge TH
    Int J Obes (Lond); 2016 Feb; 40(2):275-80. PubMed ID: 26315843
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects.
    Holdstock C; Lind L; Engstrom BE; Ohrvall M; Sundbom M; Larsson A; Karlsson FA
    Int J Obes (Lond); 2005 Oct; 29(10):1275-80. PubMed ID: 16010285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
    Luo P; Yu H; Zhao X; Bao Y; Hong CS; Zhang P; Tu Y; Yin P; Gao P; Wei L; Zhuang Z; Jia W; Xu G
    J Proteome Res; 2016 Apr; 15(4):1288-99. PubMed ID: 26889720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss.
    Kayser BD; Lhomme M; Dao MC; Ichou F; Bouillot JL; Prifti E; Kontush A; Chevallier JM; Aron-Wisnewsky J; Dugail I; Clément K
    Int J Obes (Lond); 2017 Jun; 41(6):917-925. PubMed ID: 28280270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using the hyperinsulinemic euglycemic clamp to assess insulin sensitivity at 3 months following Roux-en-Y gastric bypass surgery in type 2 diabetes patients with BMI <35 kg/m
    Zhao L; Zhu L; Su Z; Liu Y; Li P; Yang X; Li W; Tan L; Sun X; Zhu S
    Int J Surg; 2017 Feb; 38():90-94. PubMed ID: 28043929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Body fat mass and distribution as predictors of metabolic outcome and weight loss after Roux-en-Y gastric bypass.
    Eriksson Hogling D; Rydén M; Bäckdahl J; Thorell A; Arner P; Andersson DP
    Surg Obes Relat Dis; 2018 Jul; 14(7):936-942. PubMed ID: 29705562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early Increases in Bile Acids Post Roux-en-Y Gastric Bypass Are Driven by Insulin-Sensitizing, Secondary Bile Acids.
    Albaugh VL; Flynn CR; Cai S; Xiao Y; Tamboli RA; Abumrad NN
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1225-33. PubMed ID: 26196952
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does the RYGB common limb length influence hypertension remission and cardiometabolic risk factors? Data from the GATEWAY trial.
    Schiavon CA; Santos RN; Santucci EV; Noujaim PM; Cavalcanti AB; Drager LF
    Surg Obes Relat Dis; 2019 Feb; 15(2):211-217. PubMed ID: 30679036
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients.
    Huang H; Kasumov T; Gatmaitan P; Heneghan HM; Kashyap SR; Schauer PR; Brethauer SA; Kirwan JP
    Obesity (Silver Spring); 2011 Nov; 19(11):2235-40. PubMed ID: 21546935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss.
    Handisurya A; Riedl M; Vila G; Maier C; Clodi M; Prikoszovich T; Ludvik B; Prager G; Luger A; Kautzky-Willer A
    Obes Surg; 2010 Feb; 20(2):198-203. PubMed ID: 19506980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of RYGB on Oxidative Stress in Adults: a 6-Year Follow-up Study.
    Tozzo C; Moreira EAM; de Freitas MB; da Silva AF; Portari GV; Wilhelm Filho D
    Obes Surg; 2020 Sep; 30(9):3301-3308. PubMed ID: 32382963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maximizing Weight Loss After Roux-en-Y Gastric Bypass May Decrease Risk of Incident Organ Cancer.
    Hunsinger MA; Wood GC; Still C; Petrick A; Blansfield J; Shabahang M; Benotti P
    Obes Surg; 2016 Dec; 26(12):2856-2861. PubMed ID: 27129801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The relation between pro-oxidant antioxidant balance and glycolipid profile, 6 months after gastric bypass surgery.
    Banazadeh V; Nematy M; Ghayour Mobarhan M; Tavallaie S; Esmaily H; Jangjoo A
    Surg Obes Relat Dis; 2018 Mar; 14(3):361-367. PubMed ID: 29339032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
    Peterli R; Wölnerhanssen BK; Peters T; Vetter D; Kröll D; Borbély Y; Schultes B; Beglinger C; Drewe J; Schiesser M; Nett P; Bueter M
    JAMA; 2018 Jan; 319(3):255-265. PubMed ID: 29340679
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nutritional profile of patients before and after Roux-en-Y gastric bypass: 3-year follow-up.
    Blume CA; Boni CC; Casagrande DS; Rizzolli J; Padoin AV; Mottin CC
    Obes Surg; 2012 Nov; 22(11):1676-85. PubMed ID: 22684818
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.